MSB 3.21% $1.13 mesoblast limited

Ann: Rexlemestrocel Reduces Heart Attacks/Strokes/CV Death in CHF, page-380

  1. 3,952 Posts.
    lightbulb Created with Sketch. 1352
    What complete and utter nonsense. MSB and there then partner have always been following FDA guidance. You don't get a trial of this nature up and running with out FDA guidance.



 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.